Medication
Why does a child taking ciclosporin for aplastic anaemia need blood drug level tests?
Blood drug levels help doctors understand how much medicine the body is exposed to. They must be assessed alongside blood counts, liver and kidney function, and blood pressure. Parents should not adjust treatment themselves based on the result.
Blood counts and drug levels answer different questions
The National Health Commission's 2019 guidance on diagnosing and treating aplastic anaemia in children requires monitoring of blood drug levels, liver and kidney function, and blood pressure during ciclosporin treatment.[1] A complete blood count records the state of the blood cells; a drug level reflects the amount of medicine in the blood at a particular sampling time. Together, these provide information for the doctor's assessment of treatment.
Patient information from the Tibet Autonomous Region drug regulatory authority also explains that drug concentrations change over time.[2] Even with the same tablet and the same number on a report, direct comparison with previous tests is difficult without the blood sampling time and medication records.

Bring timing records together with reports and medication details
Beijing Tsinghua Changgung Hospital's patient information on blood sampling explains that the specific sampling time for a drug level test must follow the doctor's instructions, and the time of the last dose should be checked before blood is taken.[3] Useful records for parents to bring include the medicine packaging or prescription, what the child actually took, the previous report, and the exact times of the last dose and blood sampling.
| Test or record | Main information provided | How to hand it over at follow-up |
|---|---|---|
| Complete blood count | Changes in blood cells | Arrange previous reports by date |
| Blood drug level | Drug exposure at a specific time | Record both dose and sampling times |
| Liver and kidney function, and blood pressure | Safety indicators requiring attention during treatment | Provide these with the follow-up records requested by the doctor |
When attending another hospital in China for follow-up, avoid providing only a screenshot with the date and units cropped out. Ask the receiving team to check the original report and explain which test is needed this time and how sampling should be arranged. This article does not give parents instructions for changing medication on the day of testing themselves.[1–3]
If one result changes, first ask whether the comparison conditions match
The 2019 paediatric guidance gives specific instructions for ciclosporin use in children.[1] This article concerns follow-up for childhood aplastic anaemia. Its treatment approach must not be applied directly to adults or to people taking medicines to prevent rejection after a transplant.
When results arrive, ask the doctor whether this test used the same sampling measure, units and timing conditions as the previous one, and whether recently added medicines or changes in the child's health need to be considered when interpreting it. Clarifying these questions helps subsequent assessment more than changing the dose yourself based on a report's high or low arrows. Specific treatment adjustments and whether to continue medication are decisions for the child's responsible haematology team.
When changing hospitals, hand over the next monitoring plan too
The national guidance explicitly requires ongoing monitoring of several indicators.[1] Before leaving the clinic, ask the doctor to write down which tests are needed next and how to submit complete reports after testing where you live. If results will not be available before your return journey, establish which team will receive them and respond.
If you need coordination for care in China, you can first tell SinoCareHub about the child's condition, previous consultations and the questions you hope to resolve. Medical records need not be uploaded for the first enquiry. An adviser can explain the subsequent channel for sharing documents and the scope of assistance; the medical team determines treatment and monitoring requirements.[4]
Frequently asked questions
Can a child's ciclosporin report for aplastic anaemia be compared with target values for an adult transplant recipient?
The indication, patient group and treatment goals may differ. Ask the child's haematology team to interpret the report according to the child's own treatment plan.
If my child already took ciclosporin on the blood test day, can I still bring the result to the doctor?
Tell the blood sampling and treating teams the actual dose and sampling times. They will decide how to arrange or interpret the test. Do not conceal this information or make up for or change a dose yourself.
Need help?
Tell us about your situation and needs. Incomplete records are welcome.
Related reading
Sources and references
- National Health Commission, 2019 guidance on diagnosing and treating aplastic anaemia in children, ciclosporin section
- Tibet Autonomous Region drug regulatory authority, 2021-03-15
- Beijing Municipal Health Commission, republishing Tsinghua Changgung Hospital patient information, 2024-06-11
- SinoCareHub enquiry page